Us Bancorp \De\ Alx Oncology Holdings Inc Transaction History

Us Bancorp \De\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$8.23 - $15.14 $534 - $984	65 New	65 $1,000
Q2 2022 Aug 01, 2022	SELL	$5.89 - $19.46 $3,398 - $11,228	-577 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$13.65 - $22.06 $2,648 - $4,279	194 Added 50.65%	577 $9,000
Q4 2021 Feb 11, 2022	BUY	$21.49 - $74.4 $1,590 - $5,505	74 Added 23.95%	383 $9,000
Q3 2021 Nov 10, 2021	BUY	$52.51 - $80.91 $15,700 - $24,192	299 Added 2990.0%	309 $23,000
Q2 2021 Aug 05, 2021	BUY	$52.2 - $75.23 $522 - $752	10 New	10 $1,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $74.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.